INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 128 filers reported holding INOVIO PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $48,979 | -36.4% | 61,827 | +25.3% | 0.00% | – |
Q4 2022 | $76,966 | +113.8% | 49,337 | +134.3% | 0.00% | – |
Q3 2022 | $36,000 | -92.5% | 21,056 | -83.7% | 0.00% | – |
Q1 2019 | $482,000 | -2.6% | 129,102 | +4.3% | 0.00% | -100.0% |
Q4 2018 | $495,000 | -62.2% | 123,817 | -17.7% | 0.00% | -50.0% |
Q1 2016 | $1,310,000 | +41.8% | 150,437 | +9.5% | 0.00% | +100.0% |
Q4 2015 | $924,000 | – | 137,430 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Defender Capital, LLC. | 648,800 | $1,920,000 | 1.55% |
Round Table Services, LLC | 339,391 | $998,000 | 0.31% |
ARK Investment Management | 3,955,017 | $11,628,000 | 0.29% |
Nikko Asset Management Americas, Inc. | 4,884,100 | $14,359,000 | 0.28% |
WASATCH ADVISORS LP | 6,735,726 | $19,803,000 | 0.19% |
Cedar Brook Financial Partners, LLC | 41,500 | $122,000 | 0.06% |
Unified Trust Company, N.A. | 15,716 | $46,000 | 0.03% |
Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors | 13,500 | $40,000 | 0.03% |
STONERIDGE INVESTMENT PARTNERS LLC | 16,914 | $50,000 | 0.02% |
Sumitomo Mitsui Trust Holdings, Inc. | 4,884,100 | $14,359,000 | 0.01% |